Trial
NCT00459108
Dasatinib in Treating Patients With Advanced Liver Cancer That Cannot Be Removed by Surgery
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
National Cancer Institute (NCI)
Collaborators
—
Condition
Adult Primary Hepatocellular Carcinoma
Intervention
dasatinib
Why stopped
Halted early for futility.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-04-19